Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Pharmacotherapy: Combination pharmacotherapy for cardiovascular disease. (0.11 sec) 

Combination pharmacotherapy for cardiovascular disease

- annals.org
C Pharmacotherapy… - Annals of Internal Medicine, 2005 - Am Coll Physicians
Cardiovascular disease (CVD) is the major cause of death in developed countries and is rapidly
becoming the major cause of death in the developing world. The increasing rates of obesity and
type 2 diabetes, however, may slow the current favorable trends for deaths attributable to ...
Cited by 25 - Related articles - All 3 versions

Multi-Constituent Cardiovascular Pills (MCCP)-Challenges and Promises of …


MJ Jamieson, M Naghavi - Current pharmaceutical design, 2007 - ingentaconnect.com
1 Clinical Associate Professor of Medicine and Pharmacology, University of Texas Health Science
Center, San Antonio, Texas and Scientific Advisor to the Association for Eradication of Heart
Attack (AEHA) and ... The Association for Eradication of Heart Attack, Houston, TX, USA
Cited by 4 - Related articles - BL Direct - All 4 versions

Benefits, challenges, and registerability of the polypill

- oxfordjournals.org
P Sleight, H Pouleur, F Zannad - European heart journal, 2006 - Eur Soc Cardiology
Guidelines for the management of cardiovascular disease (CVD) stress the importance of treating
global risk, rather than individual risk, factors. Patients at high cardiovascular (CV) risk, for
example, benefit from a combination of aspirin, antihypertensive agents, lipid-lowering ...
Cited by 34 - Related articles - BL Direct - All 4 versions

“Polypill” to fight cardiovascular disease: Now who's playing God?

- nih.gov [PDF] 
S Taylor, A Konings - BMJ: British Medical Journal, 2003 - pubmedcentral.nih.gov
Patients before populations Editor—Wald and Law's provocative paper and the accompanying
editorial on the “Polypill” was disappointing in focusing only on the advantage to the population
and ignoring the individual's views of the benefit he or she would wish to see from taking ...
Cited by 2 - Related articles - All 5 versions

Prospects and possible pitfalls of a preventive Polypill: confessions of a health …


LW Green - European Journal of Clinical Nutrition, 2005 - nature.com
A proposal by Wald and Law (2003) for a single pill containing a statin, three half-dose
antihypertensives, aspirin, and folic acid, met with a storm of controversy and seemed to have
been relegated as much to the fanciful as to the accolades it might have deserved. The ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Combination Pharmacotherapy for Cardiovascular Disease Prevention Threat or …


KMV Narayan, GA Mensah, S Sorensen, YJ Cheng, … - American journal of …, 2005 - Elsevier
In a series of three papers in the British Medical Journal (June 28, 2003), Wald et al. proposed
that the Polypill™ can reduce the incidence of coronary heart disease by 88%, and stroke by
80%, if taken by all people aged ≥55, as well as people of any age with existing ...
Cited by 4 - Related articles - All 11 versions

East Asians and South Asians, and Asian and Pacific-Islander Americans


PC Deedwania, R Gupta - Preventive Cardiology: A Practical …, 2005 - books.google.com
East Asians and South Asians, and Asian and Pacific-Islander Americans 20 Prakash C. Deedwania
Rajeev Gupta KEY POINTS • Cardiovascular disease is a major problem among Asians and
Pacific Islanders, causing high morbidity and mortality. Hypertension is the most common ...
Cited by 7 - Related articles - All 2 versions

Polypill holds promise for people with chronic disease


J Wise - Bulletin of the World Health Organization, 2005 - SciELO Public Health
A “polypill” containing a fixed-dose of aspirin, a statin and one or two blood- pressure-lowering
drugs, has enormous potential in developing countries, where the rate of cardiovascular disease
is rising rapidly, according to an expert working party. No fixed-dose combination pill of ...
Cited by 11 - Related articles - All 5 versions

Management issues in the metabolic syndrome


PC Deedwania, R Gupta - JOURNAL-ASSOCIATION OF PHYSICIANS OF …, 2006 - japi.org
Multifaceted etiology of cardiovascular diseases,especially coronary heart disease, has beenrecognized
for a long time1 and clustering of multiplecardiovascular risk factors has been known for at least80
years. Kylin initially reported that hypertension,hyperglycemia and high uric acid levels in ...
Cited by 13 - Related articles - Cached - BL Direct - All 6 versions

The polypill: at what price would it become cost effective?

- nih.gov
OH Franco, EW Steyerberg, C de Laet - British Medical Journal, 2006 - jech.bmj.com
Oscar H Franco, Ewout W Steyerberg and Chris de Laet ... Data supplement http://jech.bmj.com
/cgi/content/full/60/3/213/DC1 "Correction" ... References http://jech.bmj.com/cgi/content/full/60
/3/213#BIBL This article cites 15 articles, 12 of which can be accessed free at:
Cited by 14 - Related articles - BL Direct - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google